R&D

News

Cell therapy produces encouraging first results in eye trial

UK-based biotech ReNeuron has announced encouraging results from an early stage trial of its cell therapy for the rare blindness-causing disease, retinitis pigmentosa (RP).

News

UK biotech gets grant for further trial of osteoarthritis dr...

UK biotech AKL Research and Development (AKLRD) has received a grant from a UK government-backed innovation body to develop its potentially “game changing” osteoarthritis drug.

News

Artificial neuron in concept of artificial intelligence. Wall-shaped binary codes make transmission lines of pulses and/or information in an analogy to a microchip. Neural network and data transmission.

UCB joins with UK charity to research new epilepsy drugs

Belgium’s UCB has joined forces with the UK’s Epilepsy Society in a collaboration aimed at finding treatments for people who have the disease, but do not respond to current treatments.

News

Pharma companies clear the R&D decks in Q4

The fourth-quarter results season has already seen a host of unwanted projects cleared from pharma companies' pipelines as they tighten their focus on the projects with the most chance of a

Views & Analysis

R&D roundup: the ups and downs of CRISPR and Alzheimer’s

While the controversy surrounding Vertex Pharma’s cystic fibrosis drug in the UK grows more intense, the US firm has announced that it is licensing back two gene editing compounds that can

News